These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34060436)

  • 21. UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.
    Gregg K; Hakki M; Kaul DR
    Transpl Infect Dis; 2014 Apr; 16(2):320-3. PubMed ID: 24621186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of crystals in kidneys of AIDS patients treated with foscarnet.
    Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H
    Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety profile of the concomitant use of foscarnet and aerosolized pentamidine in allogeneic hematopoietic stem cell transplantation recipients.
    Takahashi M; Takahashi K; Inose R; Sugimoto T; Koh H; Hino M; Nagayama K
    Transpl Infect Dis; 2020 Feb; 22(1):e13239. PubMed ID: 31883423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommended foscarnet dose is not associated with improved outcomes in cytomegalovirus salvage therapy.
    Spinner ML; Lam SW; Koval CE; Athans V
    J Clin Virol; 2019 Nov; 120():12-16. PubMed ID: 31514101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of foscarnet is associated with an increased incidence of acute kidney injury in hematopoietic stem cell transplant patients: A retrospective observational study.
    Inose R; Takahashi K; Takahashi M; Sugimoto T; Nanno S; Hino M; Nagayama K
    Transpl Infect Dis; 2022 Apr; 24(2):e13804. PubMed ID: 35114030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.
    Hubacek P; Keslova P; Formankova R; Pochop P; Cinek O; Zajac M; Lochmanova J; Stary J; Sedlacek P
    Pediatr Transplant; 2009 Nov; 13(7):919-22. PubMed ID: 19067913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation.
    Reusser P; Einsele H; Lee J; Volin L; Rovira M; Engelhard D; Finke J; Cordonnier C; Link H; Ljungman P;
    Blood; 2002 Feb; 99(4):1159-64. PubMed ID: 11830461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of low cytomegalovirus viral load thresholds for preemptive antiviral therapy in hematopoietic cell transplant recipients].
    Li L; Wang Y; Yan CH; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):191-195. PubMed ID: 29518863
    [No Abstract]   [Full Text] [Related]  

  • 29. Unusual prolonged hypocalcemia due to foscarnet in a patient with AIDS.
    Guillaume MP; Karmali R; Bergmann P; Cogan E
    Clin Infect Dis; 1997 Oct; 25(4):932-3. PubMed ID: 9356819
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
    Shapira MY; Resnick IB; Chou S; Neumann AU; Lurain NS; Stamminger T; Caplan O; Saleh N; Efferth T; Marschall M; Wolf DG
    Clin Infect Dis; 2008 May; 46(9):1455-7. PubMed ID: 18419454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
    J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Deliliers GL; Platzbecker U; Matthes-Martin S; Bacigalupo A; Einsele H; Ullmann J; Musso M; Trenschel R; Ribaud P; Bornhäuser M; Cesaro S; Crooks B; Dekker A; Gratecos N; Klingebiel T; Tagliaferri E; Ullmann AJ; Wacker P; Cordonnier C
    Blood; 2001 Jan; 97(2):388-92. PubMed ID: 11154213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
    Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
    Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant].
    Najima Y; Ohashi K; Ando M; Koshida A; Yamashita T; Akiyama H; Sakamaki H
    Rinsho Ketsueki; 2008 Jan; 49(1):40-5. PubMed ID: 18277595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
    Aschan J; Ringdén O; Ljungman P; Lönnqvist B; Ohlman S
    Scand J Infect Dis; 1992; 24(2):143-50. PubMed ID: 1322557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penile erosions associated with foscarnet therapy in a child.
    Hick RW; Prose N
    Pediatr Dermatol; 2010; 27(3):302-3. PubMed ID: 20609154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of gastrointestinal cytomegalovirus infection with twice-daily foscarnet: a pilot study of safety, efficacy, and pharmacokinetics in patients with AIDS.
    Dieterich DT; Poles MA; Lew EA; Martin-Munley S; Johnson J; Nix D; Faust MJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1226-30. PubMed ID: 9174175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients.
    Domingo W; Nguyen IT; Johnsrud JJ; Brown JW
    Transplant Cell Ther; 2021 Jul; 27(7):622.e1-622.e5. PubMed ID: 33891883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Katlama C; Dohin E; Caumes E; Cochereau-Massin I; Brancon C; Robinet M; Rogeaux O; Dahan R; Gentilini M
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S18-24. PubMed ID: 1318363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.